(Q30429578)

21 June 2017

title

Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines (English)

1 reference

21 June 2017

3

1 reference

21 June 2017

Salim Abdool Karim

6

0 references

Bruce D. Walker

7

object named as

Bruce D Walker

1 reference

21 June 2017

10

Gary J Nabel

1 reference

21 June 2017

2

Nina D Russell

1 reference

21 June 2017

Wayne C Koff

1

1 reference

21 June 2017

Mark B Feinberg

4

1 reference

21 June 2017

John W Shiver

5

1 reference

21 June 2017

Margaret G McGlynn

8

1 reference

21 June 2017

Chidi Victor Nweneka

9

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

21 June 2017

1 reference

21 June 2017

volume

31 Suppl 2

1 reference

21 June 2017

page(s)

B204-8

1 reference

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.115

10.1016/J.VACCINE.2012.10.115

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference